A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and Multiple Doses of CG-0416 in Healthy Participants.

Clinical trial NCT07724431 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07724431
Sponsor: HongKong Curegene Innovation Co., Limited
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight and Obesity

Start date: 2026-07-01
Primary completion: 2027-03-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.